Table 2.
Control group (n = 132) |
Obesity group (n = 165) |
p values* | |
---|---|---|---|
Prepubertal subgroup | |||
FSH (UI/L) | 1.5 (1.3–1.6) | 1.6 (1.0–2.2) | 0.754 |
LH (UI/L) | 0.05 (0.04–0.06) | 0.050 (0.03–0.06) | 0.275 |
ratio LH/FSH | 0.03 (0.03–0.04) | 0.04 (0.03–0.04) | 0.314 |
Estradiol (pg/mL) | 9.1 (8.5–9.7) | 9.5 (9.2–9.8) | 0.126 |
ACTH (ng/L) | 19.8 (15.9–23.6) | 22.3 (19.3–25.3) | 0.299 |
Cortisol (μg/dL) | 8.6 (7.7–0.6) | 8.1 (7.2–9.0) | 0.421 |
17-OH-P (μg/L) | 0.8 (0.6–1.0) | 0.80 (0.7–0.8) | 0.435 |
DHE-S (μg/dL) | 61.0 (53.3–68.7) | 71.7 (64.2–79.2) | 0.253 |
Androstenedione (μg/L) | 0.4 (0.3–0.5) | 0.4 (0.3–0.4) | 0.752 |
Testosterone (ng/mL) | 0.1 (0.09–0.11) | 0.11 (0.10–0.12) | 0.674 |
FT (ng/L) | 0.33 (0.27–0.39) | 0.40 (0.32–0.48) | 0.220 |
Control group (n = 111) |
Obesity group (n = 118) |
p values* | |
---|---|---|---|
Early puberty subgroup | |||
FSH (UI/L) | 3.7 (3.3–4.1) | 3.8 (3.5–4.2) | 0.529 |
LH (UI/L) | 0.7 (0.5–0.9) | 2.5 (2.0–2.9) | 0.001 |
ratio LH/FSH | 0.19 (0.15–0.24) | 0.6 (0.5–0.7) | 0.001 |
Estradiol (pg/mL) | 24.6 (17.6–31.5) | 31.0 (24.4–37.5) | 0.310 |
ACTH (ng/L) | 18.1 (14.9–21.1) | 29.6 (24.8–34.3) | 0.003 |
Cortisol (μg/dL) | 9.2 (6.8–11.5) | 11.5 (9.6–13.3) | 0.389 |
17-OH-P (μg/L) | 0.8 (0.7–1.0) | 0.9 (0.7–1.1) | 0.318 |
DHE-S (μg/dL) | 69.6 (61.0–78.3) | 143.8 (130.6–156.9) | 0.001 |
Androstenedione (μg/L) | 0.6 (0.5–0.7) | 1.4 (1.2–1.6) | 0.001 |
Testosterone (ng/mL) | 0.14 (0.10–0.18) | 0.23 (0.21–0.25) | 0.001 |
FT (ng/L) | 0.6 (0.4–0.7) | 1.3 (1.1–1.3) | 0.001 |
*Student’s t test